MetaCap

Achieve Life Sciences Quarterly Income Statement

NASDAQ: QUITHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

5.56-0.31 (-5.28%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Achieve Life Sciences revenue and earnings

Achieve Life Sciences reported a net loss of $12.1 million, compared with a loss of $14.4 million a year earlier. Diluted earnings per share came in at -$0.11.

Summary generated from market data by MetaCap's automated system. Methodology

Achieve Life Sciences income statement (quarterly)

Achieve Life Sciences quarterly income statement
Quarter (USD)Q3 20262026-09-30Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q1 20242024-03-31Q4 20232023-12-31
Research & Development————5.32M6.71M7.10M7.30M7.61M5.11M2.80M2.11M
Interest Expense258.00K277.00K274.00K251.00K192.00K191.00K185.00K197.00K366.00K804.00K813.00K787.00K
Other Income (Expense)8.43M-56.38M295.00K69.00K251.00K-155.00K67.00K-170.00K-46.00K-30.00K-512.00K-1.09M
Net Income-12.11M-74.77M-10.17M-14.66M-14.44M-12.72M-12.83M-12.36M-12.51M-8.46M-6.49M-5.48M
Net Income growth (YoY)————————————
EPS (Basic)-0.11-0.80-0.19-0.23-0.28-0.37-0.37-0.37-0.36-0.25-0.26-0.23
EPS (Diluted)-0.11-0.80-0.19-0.23-0.28-0.37-0.37-0.37-0.36-0.25-0.26-0.23
Shares Outstanding (Basic)105.48M93.51M53.38M—51.02M34.69M34.69M—34.36M34.32M25.05M—
Shares Outstanding (Diluted)105.48M93.51M53.38M—51.02M34.69M34.69M—34.36M34.32M25.05M—

This table shows 12 quarterly periods of Achieve Life Sciences's income statement, from Q3 2026 back to Q4 2023, across 13 line items including operating expenses, research & development, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow QUIT's reporting calendar. What is a income statement?

More financial data